To hear about similar clinical trials, please enter your email below
Trial Title:
Three New Methods for Diagnosing Pancreas Cancer
NCT ID:
NCT00259532
Condition:
Pancreas Cancer
Conditions: Official terms:
Pancreatic Neoplasms
Study type:
Interventional
Study phase:
N/A
Overall status:
Unknown status
Study design:
Allocation:
Non-Randomized
Intervention model:
Single Group Assignment
Primary purpose:
Diagnostic
Masking:
Single
Intervention:
Intervention type:
Procedure
Intervention name:
Ultrasound and contrast agent
Description:
contrast-enhanced ultrasound combined with the gastrointestinal hormones Secretin and
Cholecystokinin, which triggers the enzyme production of pancreas
Summary:
The purpose of this project is to evaluate and compare three new methods for diagnosis,
staging, operability evaluation and treatment control of pancreas cancer. The
investigators use contrast-enhanced ultrasound combined with the gastrointestinal
hormones Secretin and Cholecystokinin, which triggers the enzyme production of pancreas.
The hormones induce an increased metabolism and thus an increased blood flow through
healthy pancreas tissue, however, not in tumor tissue. The investigators hope to be able
to use this effect diagnostically. The patients included will also have a 64-slice-CT in
order to evaluate, if an increased diagnostic safety can be reached compared to an older
CT scanning method. All patients will also be examined for the tumor marker CA 19-9.
Further, the investigators will examine if contrast-enhanced ultrasound can contribute
with information in treatment control after either surgery or medical treatment.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- suspicion of cancer of the pancreas
Gender:
All
Minimum age:
N/A
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Copenhagen University Hospital
Address:
City:
Copenhagen
Zip:
2100
Country:
Denmark
Status:
Recruiting
Contact:
Last name:
Hanne S Grossjohann, MD
Phone:
+45 35453419
Email:
hannesonder@dadlnet.dk
Investigator:
Last name:
Hanne S Grossjohann, MD
Email:
Principal Investigator
Start date:
February 2005
Completion date:
January 2009
Lead sponsor:
Agency:
University of Copenhagen
Agency class:
Other
Source:
University of Copenhagen
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT00259532
